Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
CNX And Adalvo Claim A UK First With Nitrofurantoin
Firms Announce First-To-Market Launch Of ‘Challenging’ Prolonged-Release Product
Dec 19 2024
•
By
Dave Wallace
Adalvo and CNX have claimed a UK first
(Shutterstock)
More from Generics
More from Generics Bulletin